Literature DB >> 12002984

The hyponatremic patient: a systematic approach to laboratory diagnosis.

Haralampos J Milionis1, George L Liamis, Moses S Elisaf.   

Abstract

Hyponatremia (serum sodium level less than 134 mmol/L) is a common electrolyte disturbance. Its high prevalence and potential neurologic sequelae make a logical and rigorous differential diagnosis mandatory before any therapeutic intervention. A history of concurrent illness and medication use as well as the assessment of extracellular volume status on physical examination may provide useful clues as to the pathogenesis of hyponatremia. Measurement of the effective serum tonicity (serum osmolality less serum urea level) is the first step in the laboratory evaluation. In patients with normal or elevated effective serum osmolality (280 mOsm/kg or greater), pseudohyponatremia should be excluded. In the hypo-osmolar state (serum osmolality less than 280 mOsm/kg), urine osmolality is used to determine whether water excretion is normal or impaired. A urine osmolality value of less than 100 mOsm/kg indicates complete and appropriate suppression of antidiuretic hormone secretion. A urine sodium level less than 20 mmol/L is indicative of hypovolemia, whereas a level greater than 40 mmol/L is suggestive of the syndrome of inappropriate antidiuretic hormone secretion. Levels of hormones (thyroid-stimulating hormone and cortisol) and arterial blood gases should be determined in difficult cases of hyponatremia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12002984      PMCID: PMC100882     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  45 in total

1.  Hyponatremia: evaluating the correction factor for hyperglycemia.

Authors:  T A Hillier; R D Abbott; E J Barrett
Journal:  Am J Med       Date:  1999-04       Impact factor: 4.965

Review 2.  Epidemiology, pathophysiology, and management of hyponatremic encephalopathy.

Authors:  C L Fraser; A I Arieff
Journal:  Am J Med       Date:  1997-01       Impact factor: 4.965

Review 3.  Sodium.

Authors:  S Kumar; T Berl
Journal:  Lancet       Date:  1998-07-18       Impact factor: 79.321

4.  "Beer potomania" in non-beer drinkers: effect of low dietary solute intake.

Authors:  S M Thaler; I Teitelbaum; T Berl
Journal:  Am J Kidney Dis       Date:  1998-06       Impact factor: 8.860

5.  Electrolyte abnormalities in elderly patients admitted to a general medical ward.

Authors:  M S Elisaf; H J Milionis; K C Siamopoulos
Journal:  Geriatr Nephrol Urol       Date:  1997

Review 6.  Language guiding therapy: the case of dehydration versus volume depletion.

Authors:  K Mange; D Matsuura; B Cizman; H Soto; F N Ziyadeh; S Goldfarb; E G Neilson
Journal:  Ann Intern Med       Date:  1997-11-01       Impact factor: 25.391

7.  Hyponatraemia, hypothyroidism, and role of arginine-vasopressin.

Authors:  F W Hanna; M F Scanlon
Journal:  Lancet       Date:  1997-09-13       Impact factor: 79.321

8.  Electrolyte disturbances in beer drinkers. A specific "hypo-osmolality syndrome".

Authors:  T Hilden; T L Svendsen
Journal:  Lancet       Date:  1975-08-09       Impact factor: 79.321

Review 9.  Regulation of renal urate excretion: a critical review.

Authors:  J K Maesaka; S Fishbane
Journal:  Am J Kidney Dis       Date:  1998-12       Impact factor: 8.860

10.  Chronic hyponatremia due to reset osmostat in a patient with colon cancer.

Authors:  M S Elisaf; A Konstantinides; K C Siamopoulos
Journal:  Am J Nephrol       Date:  1996       Impact factor: 3.754

View more
  30 in total

1.  [A 25-year-old patient with colonic pseudo-obstruction, hyponatremia, hypertension, and diffuse pain].

Authors:  Philipp Lutz; Daniel Maring; Henriette J Tschampa; Tilman Sauerbruch
Journal:  Med Klin (Munich)       Date:  2010-04

Review 2.  Best practice in primary care pathology: review 8.

Authors:  W S A Smellie; K K Hampton; R Bowley; R Bowlees; S C Martin; N Shaw; J Hoffman; J P Ng; S M Mackenzie; C van Heyningen
Journal:  J Clin Pathol       Date:  2006-12-15       Impact factor: 3.411

3.  Hyponatraemia and hypernatraemia: pitfalls in testing.

Authors:  W Stuart A Smellie; A Heald
Journal:  BMJ       Date:  2007-03-03

4.  Hyponatremia and SIADH.

Authors:  Simon Smitz
Journal:  CMAJ       Date:  2002-09-03       Impact factor: 8.262

5.  Prolonged hyponatremia due to hypopituitarism in a patient with non-ST-elevation myocardial infarction.

Authors:  Kyohei Marume; Yuichiro Arima; Motoyuki Igata; Takeshi Nishikawa; Eiichiro Yamamoto; Megumi Yamamuro; Kenichi Tsujita; Tomoko Tanaka; Koichi Kaikita; Seiji Hokimoto; Hisao Ogawa
Journal:  J Cardiol Cases       Date:  2014-08-30

6.  Universal mobile electrochemical detector designed for use in resource-limited applications.

Authors:  Alex Nemiroski; Dionysios C Christodouleas; Jonathan W Hennek; Ashok A Kumar; E Jane Maxwell; Maria Teresa Fernández-Abedul; George M Whitesides
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-04       Impact factor: 11.205

7.  Letter regarding: Managing severe peripartum hyponatraemia: A case report, Obstetric Medicine: The Medicine of Pregnancy.

Authors:  Adam Morton
Journal:  Obstet Med       Date:  2015-02-27

8.  Symptomatic hyponatremia as a presenting sign of hypothalamic-pituitary disease: a syndrome of inappropriate secretion of antidiuretic hormone (SIADH)-like glucocorticosteroid responsive condition.

Authors:  D Olchovsky; D Ezra; I Vered; M Hadani; I Shimon
Journal:  J Endocrinol Invest       Date:  2005-02       Impact factor: 4.256

9.  Syndrome of inappropriate antidiuretic hormone secretion (SIADH) or hyponatraemia associated with valproic Acid: four case reports from the Netherlands and a case/non-case analysis of vigibase.

Authors:  Erna Beers; Eugène P van Puijenbroek; Imke H Bartelink; Carolien M J van der Linden; Paul A F Jansen
Journal:  Drug Saf       Date:  2010-01-01       Impact factor: 5.606

Review 10.  Salt and water: a simple approach to hyponatremia.

Authors:  Karen E Yeates; Michael Singer; A Ross Morton
Journal:  CMAJ       Date:  2004-02-03       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.